(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1348747 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NR4A3 mRNA CTD PMID:22079256 (R)-mevalonic acid multiple interactions ISO RGD:1348747 6480464 Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of NR4A3 mRNA] CTD PMID:16005304 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of NR4A3 protein CTD PMID:17337753 15-acetyldeoxynivalenol increases expression ISO RGD:1348747 6480464 15-acetyldeoxynivalenol results in increased expression of NR4A3 mRNA CTD PMID:23792671 17beta-estradiol increases expression ISO RGD:1348747 6480464 Estradiol results in increased expression of NR4A3 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62174 6480464 Tetrachlorodibenzodioxin results in increased expression of NR4A3 mRNA CTD PMID:19933214 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NR4A3 mRNA CTD PMID:33387578 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:1348747 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of NR4A3 mRNA] CTD PMID:16005304 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:62174 6480464 3 more ... CTD PMID:30312631 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:62174 6480464 3 more ... CTD PMID:30312631 4,4'-diaminodiphenylmethane decreases expression ISO RGD:62174 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of NR4A3 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NR4A3 mRNA CTD PMID:26186136 4-hydroxyphenyl retinamide increases expression ISO RGD:62174 6480464 Fenretinide results in increased expression of NR4A3 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NR4A3 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NR4A3 mRNA CTD PMID:25825206 6alpha-methylprednisolone decreases expression ISO RGD:1348747 6480464 Methylprednisolone results in decreased expression of NR4A3 mRNA CTD PMID:19192274 8-Br-cAMP increases expression ISO RGD:1348747 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A3 mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of NR4A3 mRNA CTD PMID:31881176 acetylsalicylic acid increases expression ISO RGD:1348747 6480464 Aspirin results in increased expression of NR4A3 mRNA CTD PMID:15928584 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of NR4A3 mRNA CTD PMID:22197712 all-trans-retinoic acid multiple interactions ISO RGD:1348747 6480464 [Tretinoin co-treated with Ascorbic Acid] results in increased expression of NR4A3 mRNA CTD PMID:16443354 all-trans-retinoic acid increases expression ISO RGD:1348747 6480464 Tretinoin results in increased expression of NR4A3 mRNA CTD PMID:23724009 , PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NR4A3 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:1348747 6480464 aristolochic acid I results in increased expression of NR4A3 mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:62174 6480464 Arsenic results in decreased expression of NR4A3 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:62174 6480464 Arsenic results in decreased expression of NR4A3 mRNA CTD PMID:19654921 arsenite(3-) affects expression ISO RGD:1348747 6480464 arsenite affects the expression of NR4A3 mRNA CTD PMID:22959463 arsenite(3-) increases methylation ISO RGD:1348747 6480464 arsenite results in increased methylation of NR4A3 promoter CTD PMID:23974009 astemizole increases expression EXP 6480464 Astemizole results in increased expression of NR4A3 mRNA CTD PMID:20221588 atrazine increases expression ISO RGD:1348747 6480464 Atrazine results in increased expression of NR4A3 mRNA CTD PMID:18461179 azathioprine decreases expression ISO RGD:1348747 6480464 Azathioprine results in decreased expression of NR4A3 mRNA CTD PMID:19192274 bathocuproine disulfonic acid multiple interactions ISO RGD:1348747 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NR4A3 mRNA] CTD PMID:15477007 benzene increases expression ISO RGD:1348747 6480464 Benzene results in increased expression of NR4A3 mRNA CTD PMID:19162166 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of NR4A3 mRNA CTD PMID:21839799 benzo[a]pyrene increases expression ISO RGD:1348747 6480464 Benzo(a)pyrene results in increased expression of NR4A3 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:1348747 6480464 Benzo(a)pyrene results in decreased methylation of NR4A3 5' UTR CTD PMID:27901495 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of NR4A3 mRNA CTD PMID:19560483 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NR4A3 promoter CTD PMID:23359474 bisphenol A increases expression ISO RGD:62174 6480464 bisphenol A results in increased expression of NR4A3 mRNA CTD PMID:14967926 , PMID:32156529 bisphenol A affects methylation ISO RGD:62174 6480464 bisphenol A affects the methylation of NR4A3 promoter CTD PMID:27334623 bisphenol A decreases expression ISO RGD:1348747 6480464 bisphenol A results in decreased expression of NR4A3 mRNA CTD PMID:27685785 bisphenol A decreases expression ISO RGD:62174 6480464 bisphenol A results in decreased expression of NR4A3 mRNA CTD PMID:25594700 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NR4A3 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NR4A3 mRNA CTD PMID:26141625 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NR4A3 promoter CTD PMID:23359474 bisphenol F increases expression ISO RGD:1348747 6480464 bisphenol F results in increased expression of NR4A3 mRNA CTD PMID:33476716 bisphenol F increases expression ISO RGD:62174 6480464 bisphenol F results in increased expression of NR4A3 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:62174 6480464 1, 3-butadiene results in decreased expression of NR4A3 mRNA CTD PMID:29038090 butanal increases expression ISO RGD:1348747 6480464 butyraldehyde results in increased expression of NR4A3 mRNA CTD PMID:26079696 Butylbenzyl phthalate decreases expression EXP 6480464 butylbenzyl phthalate results in decreased expression of NR4A3 mRNA CTD PMID:19560483 C.I. Natural Red 20 multiple interactions ISO RGD:62174 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A3 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A3 mRNA] CTD PMID:25451590 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of NR4A3 mRNA CTD PMID:19167457 Calcimycin increases expression ISO RGD:62174 6480464 Calcimycin results in increased expression of NR4A3 mRNA CTD PMID:25451590 Calcimycin multiple interactions ISO RGD:62174 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A3 mRNA] CTD PMID:25451590 cannabidiol multiple interactions ISO RGD:62174 6480464 Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of NR4A3 mRNA] CTD PMID:27256343 carbonyl sulfide decreases expression EXP 6480464 carbonyl sulfide results in decreased expression of NR4A3 mRNA CTD PMID:19395590 CGP 52608 multiple interactions ISO RGD:1348747 6480464 CGP 52608 promotes the reaction [RORA protein binds to NR4A3 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:62174 6480464 Chlordecone results in increased expression of NR4A3 mRNA CTD PMID:33711761 cisplatin multiple interactions ISO RGD:1348747 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of NR4A3 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1348747 6480464 Cisplatin results in decreased expression of NR4A3 mRNA CTD PMID:27392435 cocaine increases expression EXP 6480464 Cocaine results in increased expression of NR4A3 mRNA CTD PMID:27899881 colforsin daropate hydrochloride multiple interactions ISO RGD:1348747 6480464 NR4A3 protein inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA] CTD PMID:19822197 copper(II) sulfate increases expression ISO RGD:1348747 6480464 Copper Sulfate results in increased expression of NR4A3 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1348747 6480464 Asbestos, Crocidolite results in increased expression of NR4A3 mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1348747 6480464 Asbestos, Crocidolite affects the expression of NR4A3 mRNA CTD PMID:25757056 CU-O LINKAGE increases expression ISO RGD:1348747 6480464 cupric oxide results in increased expression of NR4A3 mRNA, cupric oxide results in increased expression of NR4A3 protein CTD PMID:22077320 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of NR4A3 mRNA CTD PMID:26577399 cyclosporin A multiple interactions ISO RGD:62174 6480464 Cyclosporine inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A3 mRNA] CTD PMID:25451590 cylindrospermopsin increases expression ISO RGD:1348747 6480464 cylindrospermopsin results in increased expression of NR4A3 mRNA CTD PMID:24921660 deoxynivalenol increases expression ISO RGD:1348747 6480464 deoxynivalenol results in increased expression of NR4A3 mRNA CTD PMID:26763390 dexamethasone increases expression ISO RGD:1348747 6480464 Dexamethasone results in increased expression of NR4A3 mRNA CTD PMID:25047013 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of NR4A3 mRNA CTD PMID:19560483 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NR4A3 mRNA CTD PMID:21266533 , PMID:21745491 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NR4A3 promoter CTD PMID:23359474 dibutyl phthalate increases expression ISO RGD:62174 6480464 Dibutyl Phthalate results in increased expression of NR4A3 mRNA CTD PMID:17361019 , PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of NR4A3 mRNA CTD PMID:18636392 dieldrin increases expression ISO RGD:1348747 6480464 Dieldrin results in increased expression of NR4A3 mRNA CTD PMID:31068361 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NR4A3 mRNA CTD PMID:33729688 dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of NR4A3 mRNA CTD PMID:19560483 dorsomorphin multiple interactions ISO RGD:1348747 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR4A3 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1348747 6480464 Doxorubicin results in decreased expression of NR4A3 mRNA CTD PMID:29803840 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of NR4A3 mRNA CTD PMID:32289291 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of NR4A3 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:62174 6480464 epoxiconazole results in increased expression of NR4A3 mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:62174 6480464 Ethanol affects the expression of NR4A3 mRNA CTD PMID:30319688 fenoterol increases expression ISO RGD:62174 6480464 Fenoterol results in increased expression of NR4A3 mRNA CTD PMID:34601065 fluoranthene multiple interactions ISO RGD:62174 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A3 mRNA CTD PMID:28329830 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of NR4A3 mRNA CTD PMID:17033635 folic acid decreases expression ISO RGD:62174 6480464 Folic Acid results in decreased expression of NR4A3 mRNA CTD PMID:25006883 gemcitabine increases expression ISO RGD:1348747 6480464 Gemcitabine results in increased expression of NR4A3 mRNA CTD PMID:17039268 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NR4A3 mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NR4A3 mRNA CTD PMID:33387578 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of NR4A3 mRNA CTD PMID:24915197 graphite affects expression EXP 6480464 Graphite affects the expression of NR4A3 mRNA CTD PMID:29933104 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of NR4A3 mRNA CTD PMID:19695244 hydrogen cyanide increases expression ISO RGD:62174 6480464 Hydrogen Cyanide results in increased expression of NR4A3 mRNA CTD PMID:33914522 ionomycin multiple interactions ISO RGD:1348747 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NR4A3 mRNA], [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NR4A3 mRNA CTD PMID:15477007 isoprenaline increases expression ISO RGD:62174 6480464 Isoproterenol results in increased expression of NR4A3 mRNA CTD PMID:34601065 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of NR4A3 mRNA CTD PMID:19700661 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of NR4A3 mRNA CTD PMID:20080153 L-ascorbic acid multiple interactions ISO RGD:1348747 6480464 [Tretinoin co-treated with Ascorbic Acid] results in increased expression of NR4A3 mRNA CTD PMID:16443354 leflunomide increases expression ISO RGD:1348747 6480464 leflunomide results in increased expression of NR4A3 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1348747 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1348747 6480464 Lipopolysaccharides results in increased expression of NR4A3 mRNA CTD PMID:35811015 LY294002 multiple interactions ISO RGD:1348747 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of NR4A3 mRNA] CTD PMID:12710931 mabuterol increases expression ISO RGD:62174 6480464 mabuterol results in increased expression of NR4A3 mRNA CTD PMID:34601065 melphalan increases expression ISO RGD:1348747 6480464 Melphalan results in increased expression of NR4A3 mRNA CTD PMID:22363485 metformin decreases expression EXP 6480464 Metformin results in decreased expression of NR4A3 mRNA CTD PMID:31324951 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of NR4A3 mRNA CTD PMID:19564919 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of NR4A3 mRNA CTD PMID:19564919 methotrexate decreases expression ISO RGD:1348747 6480464 Methotrexate results in decreased expression of NR4A3 mRNA CTD PMID:19192274 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of NR4A3 gene CTD PMID:23303685 methylisothiazolinone increases expression ISO RGD:1348747 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of NR4A3 mRNA CTD PMID:31629900 milrinone increases expression EXP 6480464 Milrinone results in increased expression of NR4A3 mRNA CTD PMID:22936366 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1348747 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of NR4A3 mRNA CTD PMID:19822197 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1348747 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of NR4A3 mRNA] CTD PMID:12710931 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of NR4A3 mRNA CTD PMID:28801915 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of NR4A3 protein CTD PMID:17337753 nickel atom increases expression ISO RGD:1348747 6480464 Nickel results in increased expression of NR4A3 mRNA CTD PMID:23195993 , PMID:25583101 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of NR4A3 mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:62174 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NR4A3 mRNA CTD PMID:34911549 ozone increases expression EXP 6480464 Ozone results in increased expression of NR4A3 mRNA CTD PMID:16716893 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NR4A3 mRNA CTD PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of NR4A3 mRNA CTD PMID:32680482 paraquat increases expression ISO RGD:1348747 6480464 Paraquat results in increased expression of NR4A3 mRNA CTD PMID:34097952 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorooctanoic acid decreases expression ISO RGD:62174 6480464 perfluorooctanoic acid results in decreased expression of NR4A3 mRNA CTD PMID:30711707 permethrin increases expression EXP 6480464 Permethrin results in increased expression of NR4A3 mRNA CTD PMID:19017407 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of NR4A3 mRNA CTD PMID:31324951 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of NR4A3 mRNA CTD PMID:18158353 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1348747 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NR4A3 mRNA] more ... CTD PMID:15477007 , PMID:16979875 pioglitazone increases expression ISO RGD:62174 6480464 pioglitazone results in increased expression of NR4A3 mRNA CTD PMID:17785466 pirinixic acid increases expression ISO RGD:62174 6480464 pirinixic acid results in increased expression of NR4A3 mRNA CTD PMID:16985257 piroxicam decreases expression ISO RGD:1348747 6480464 Piroxicam results in decreased expression of NR4A3 mRNA CTD PMID:19192274 potassium chromate multiple interactions ISO RGD:1348747 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NR4A3 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1348747 6480464 potassium chromate(VI) results in increased expression of NR4A3 mRNA CTD PMID:22079256 potassium cyanide increases expression ISO RGD:62174 6480464 Potassium Cyanide results in increased expression of NR4A3 mRNA CTD PMID:33914522 potassium dichromate increases expression ISO RGD:62174 6480464 Potassium Dichromate results in increased expression of NR4A3 mRNA CTD PMID:23608068 prednisolone decreases expression ISO RGD:1348747 6480464 Prednisolone results in decreased expression of NR4A3 mRNA CTD PMID:19192274 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of NR4A3 mRNA CTD PMID:19162173 pyrrolidine dithiocarbamate multiple interactions ISO RGD:1348747 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NR4A3 mRNA] CTD PMID:15477007 quercetin affects expression EXP 6480464 Quercetin affects the expression of NR4A3 mRNA CTD PMID:18178720 raloxifene multiple interactions ISO RGD:1348747 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of NR4A3 mRNA CTD PMID:19059307 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1348747 6480464 [S-(1 more ... CTD PMID:35811015 Salmeterol xinafoate increases expression ISO RGD:62174 6480464 Salmeterol Xinafoate results in increased expression of NR4A3 mRNA CTD PMID:34601065 SB 431542 multiple interactions ISO RGD:1348747 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR4A3 mRNA CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of NR4A3 mRNA CTD PMID:19564919 Shikonin multiple interactions ISO RGD:62174 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A3 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A3 mRNA] CTD PMID:25451590 silicon dioxide decreases expression ISO RGD:1348747 6480464 Silicon Dioxide analog results in decreased expression of NR4A3 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:62174 6480464 Silicon Dioxide results in increased expression of NR4A3 mRNA CTD PMID:23221170 silicon dioxide increases expression ISO RGD:1348747 6480464 Silicon Dioxide analog results in increased expression of NR4A3 mRNA, Silicon Dioxide results in increased expression of NR4A3 mRNA CTD PMID:22300531 more ... simvastatin multiple interactions ISO RGD:1348747 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of NR4A3 mRNA], Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of NR4A3 mRNA] CTD PMID:16005304 sodium arsenite increases expression ISO RGD:1348747 6480464 sodium arsenite results in increased expression of NR4A3 mRNA alternative form CTD PMID:21281968 sodium arsenite decreases expression ISO RGD:1348747 6480464 sodium arsenite results in decreased expression of NR4A3 mRNA CTD PMID:34032870 sodium aurothiomalate decreases expression ISO RGD:1348747 6480464 Gold Sodium Thiomalate results in decreased expression of NR4A3 mRNA CTD PMID:19192274 Soman increases expression EXP 6480464 Soman results in increased expression of NR4A3 mRNA CTD PMID:19281266 styrene decreases expression ISO RGD:62174 6480464 Styrene results in decreased expression of NR4A3 mRNA CTD PMID:28951217 sulforaphane decreases expression ISO RGD:1348747 6480464 sulforaphane results in decreased expression of NR4A3 mRNA CTD PMID:31838189 tamoxifen multiple interactions ISO RGD:1348747 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of NR4A3 mRNA CTD PMID:19059307 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NR4A3 mRNA CTD PMID:34492290 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of NR4A3 mRNA CTD PMID:30012374 torcetrapib increases expression ISO RGD:1348747 6480464 torcetrapib results in increased expression of NR4A3 mRNA CTD PMID:19164467 , PMID:23228038 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of NR4A3 mRNA CTD PMID:17553608 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NR4A3 mRNA CTD PMID:33387578 triphenylstannane decreases expression EXP 6480464 triphenyltin results in decreased expression of NR4A3 mRNA CTD PMID:32504733 triptonide increases expression ISO RGD:62174 6480464 triptonide results in increased expression of NR4A3 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:62174 6480464 troglitazone results in increased expression of NR4A3 mRNA CTD PMID:17785466 troglitazone decreases expression ISO RGD:62174 6480464 troglitazone results in decreased expression of NR4A3 mRNA CTD PMID:28973697 undecane increases expression EXP 6480464 undecane results in increased expression of NR4A3 protein CTD PMID:17337753 urethane increases expression ISO RGD:1348747 6480464 Urethane results in increased expression of NR4A3 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1348747 6480464 Valproic Acid affects the expression of NR4A3 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1348747 6480464 Valproic Acid results in decreased expression of NR4A3 mRNA CTD PMID:28001369 valproic acid multiple interactions ISO RGD:1348747 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR4A3 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1348747 6480464 Valproic Acid results in increased expression of NR4A3 mRNA CTD PMID:23179753 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NR4A3 mRNA CTD PMID:19015723 Y-27632 decreases expression ISO RGD:1348747 6480464 Y 27632 results in decreased expression of NR4A3 mRNA CTD PMID:16005304 zinc atom multiple interactions ISO RGD:1348747 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NR4A3 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A3 mRNA CTD PMID:16979875 , PMID:18593933 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of NR4A3 mRNA CTD PMID:19111725 zinc(0) multiple interactions ISO RGD:1348747 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NR4A3 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A3 mRNA CTD PMID:16979875 , PMID:18593933 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of NR4A3 mRNA CTD PMID:19111725
